Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 155

Sort by

Sort Order Select

Journal Articles

Validation of the artificial intelligence prediction of acute leukemia tool in a Latin American retrospective cohort

Jade Zezzi Martins do Nascimento, Aline Nishimoto, Amanda Inácio Dias Ennes, Mariana Lorenzi Savioli, Eduardo Chapchap, André Américo, Tarcila Datoguia, Leonardo Javier Arcuri, Nelson Hamerschlak, Fabio Santos

Blood (2025) 146 (Supplement 1): 4362.

https://doi.org/10.1182/blood-2025-4362

Published: 2025

Journal Articles

More than a bulk: Higher incidence of venous thromboembolism (VTE) in patients with primary mediastinal B-cell lymphoma compared to patients with bulky mediastinal Hodgkin lymphoma

Blood (2025) 146 (Supplement 1): 1361.

https://doi.org/10.1182/blood-2025-1361

Published: 2025

Journal Articles

Training program for DATA managers in hematopoietic cell transplantation and advanced cell therapy: A nine-year overview from Brazil

Cinthya Da Silva, Anderson João Simione, Flavia da Costa, Heliz Neves, Adriana Seber, Nelson Hamerschlak, Carmem Bonfim, Afonso Vigorito, Mary Flowers, Marcelo Pasquini, Fernando Barroso Duarte

Blood (2025) 146 (Supplement 1): 4647.

https://doi.org/10.1182/blood-2025-4647

Published: 2025

Journal Articles

Total marrow irradiation-based, intensified reduced-intensity conditioning regimen for haploidentical hematopoietic cell transplantation with posttransplant cyclophosphamide: A prospective study

Leonardo Arcuri, Mariana Kerbauy, Lucila Kerbauy, Juliana Rocha, Carolina Marques, Tarcila Datoguia, Jade Zezzi Martins do Nascimento, Ana de Rezende, Eduardo Weltman, Roberto Sakuraba, Andreza Ribeiro, Marcos de Lima, Nelson Hamerschlak

Blood (2025) 146 (Supplement 1): 7738.

https://doi.org/10.1182/blood-2025-7738

Published: 2025

Journal Articles

Balancing efficacy and safety: IL-15 BCMA CAR-T cells vs. 2nd generation CAR-T in preclinical myeloma model

Jamile Ramos, Cleyson Barros, Thiago Mitsugi, Lays Trajano, Erica Vidal, Ingrid Souza, Robledo Ferreira, Yasmin Mamirato, Barbara Dos Reis, Julia Azevedo, Raquel M A Paiva, Oswaldo Okamoto, Larissa Cardoso, Nelson Hamerschlak, Lucila Kerbauy

Blood (2025) 146 (Supplement 1): 7635.

https://doi.org/10.1182/blood-2025-7635

Published: 2025

Journal Articles

Impact of high-dose methotrexate in both central nervous system relapse and systemic progression in high-risk DLBCL: A retrospective analysis of a brazilian cohort

Blood (2025) 146 (Supplement 1): 3673.

https://doi.org/10.1182/blood-2025-3673

Published: 2025

Journal Articles

Impact of TBI, donor age, and transplant era on outcomes of allogeneic transplantation in acute lymphoblastic leukemia: Evidence from 748 patients in Latin America

Blood (2025) 146 (Supplement 1): 2524.

https://doi.org/10.1182/blood-2025-2524

Published: 2025

Journal Articles

Validation of baseline total metabolic tumor volume (TMTV) as a predictor of early progression (POD24) in follicular lymphoma: A retrospective study of 100 patients in Brazil.

Blood (2025) 146 (Supplement 1): 5391.

https://doi.org/10.1182/blood-2025-5391

Published: 2025

Journal Articles

Machine learning ensemble models for genetic-based classification of myeloproliferative and myelodysplastic/myeloproliferative neoplasms: Comparing a multinomial vs binomial approach

Jade Zezzi Martins do Nascimento, Amanda Inácio Dias Ennes, Mariana Lorenzi Savioli, Tarcila Datoguia, Aline Nishimoto, Carolina Marques, André Américo, Luiz Gustavo Cortes, Leonardo Javier Arcuri, Paulo Campregher, Nelson Hamerschlak, Fabio Santos

Blood (2025) 146 (Supplement 1): 7868.

https://doi.org/10.1182/blood-2025-7868

Published: 2025

Journal Articles

Manufacturing variability of CAR-T cells in patients with B-cell lymphoma: Findings from the carthiae-1 clinical trial

Raquel Paiva, Julia Teixeira Cottas de Azevedo, João Agostinho Machado-Neto, Denise Oliveira, Juliana Godoy, Keli Lima, Heitor Andrade, Mariana Velloso, Fernanda Assir, Isabel Bello, Oswaldo Okamoto, Mariana Kerbauy, Jose Kutner, Nelson Hamerschlak, Lucila Kerbauy

Blood (2025) 146 (Supplement 1): 7701.

https://doi.org/10.1182/blood-2025-7701

Published: 2025

Journal Articles

Dose Escalation shows no benefit compared to continuing ABVD in Hodgkin's lymphoma patients with an interim PET deauville score of 4

Blood (2025) 146 (Supplement 1): 1854.

https://doi.org/10.1182/blood-2025-1854

Published: 2025

Journal Articles

Healthcare inequities in Latin America outweigh the benefits of pediatric regimens in adult acute lymphoblastic leukemia

Blood (2025) 146 (Supplement 1): 288.

https://doi.org/10.1182/blood-2025-288

Published: 2025

Journal Articles

Total marrow irradiation-based, intensified reduced-intensity conditioning regimen for hematopoietic cell transplantation in patients aged 60 years or older: A prospective study

Leonardo Arcuri, Mariana Kerbauy, Lucila Kerbauy, Juliana Rocha, Carolina Marques, Tarcila Datoguia, Jade Zezzi Martins do Nascimento, Ana de Rezende, Eduardo Weltman, Andreza Ribeiro, Marcos de Lima, Nelson Hamerschlak

Blood (2025) 146 (Supplement 1): 2439.

https://doi.org/10.1182/blood-2025-2439

Published: 2025

Journal Articles

HLA and non-HLA factors in haploidentical donor selection: Insights from a brazilian single-center study

Newton Centurião, Leonardo Arcuri, Cinthya Da Silva, Mariana Kerbauy, Margareth Torres, João Guerra, Nelson Hamerschlak

Blood (2025) 146 (Supplement 1): 2435.

https://doi.org/10.1182/blood-2025-2435

Published: 2025

Journal Articles

Frontline therapy patterns and outcomes in chronic lymphocytic leukemia: A real-world, multicenter analysis from Latin America.

Celso Arrais-Rodrigues, Ana Oliver, Maria Cugliari, Luis Mario Villela Martinez, Macarena Roa, Lorena Cardozo, Marialejandra Torres Viera, Denisse Castro, Daniela Trujillo Loaiza, Leila Perobelli, Anelys García Salgado, Victoria Irigoin, Sofía Rivarola, Virginia Lema Spinelli, Jose Alvarez, Alana von Glasenapp, Camila Peña, Sally Paredes, Valeria Buccheri, Gislaine Duarte, Maura Colturato, Laura Fogliatto, Ana Ines Landoni, Sabrina ranero Ferrari, Augusto Mirolli, Marta Zerga, Miguel Pavlovsky, Nancy Cristaldo, Maria Del Rosario Custidiano, Fernando Pérez-Jacobo, Danielle De Farias, Maria Orlova, Julio Pose Cabarcos, Fernando Barroso Duarte, Etelvina Macchiavello, Sérgio Fortier, Julia Laviano, Clarisa Pagano Vilar, Nelson Hamerschlak, Vera Figueiredo, Rosa Rios Jimenez, Arianna Robles, Javier Retamales, Melanie Otañez, German Stemmelin, Henry Idrobo, Brady Beltran, Jorge Castillo, Luis Malpica, Carlos Chiattone

Blood (2025) 146 (Supplement 1): 2775.

https://doi.org/10.1182/blood-2025-2775

Published: 2025

Journal Articles

Implementation of a next generation sequencing painel for lymphoid malignancies in Brazil: First report of molecular features in a low-middle income country

Blood (2025) 146 (Supplement 1): 7066.

https://doi.org/10.1182/blood-2025-7066

Published: 2025

Journal Articles

Uncovering the genomic landscape of DLBCL in Latin America: First report of two centers from Brazil and Chile

Blood (2025) 146 (Supplement 1): 7055.

https://doi.org/10.1182/blood-2025-7055

Published: 2025

Journal Articles

GMP-compliant generation, expansion, and a preliminary safety evaluation of CMV-specific t cells using a closed system for post-transplant viral control

Luciana Marti, Mariana Kerbauy, Anita Silva, Alvina Clara Felix, Ana Carolina Stefanini, Larissa Vuitika, Larissa Amaral, Fernanda Andrade, Iago Colturato, Clarisse Machado, Nelson Hamerschlak

Blood (2025) 146 (Supplement 1): 7651.

https://doi.org/10.1182/blood-2025-7651

Published: 2025

Journal Articles

Concomitant use of venetoclax 100 mg and ketoconazole, a strong CYP3A4 inhibitor, is clinically equivalent to venetoclax 400 mg for treating relapsed or refractory chronic lymphocytic leukemia (CLL): A real-world analysis from the brazilian CLL registry.“

Gabriel Cunha, Pedro Perez, Fernanda Marques, Verena Pfister, Rodrigo Santucci, Milton Aranha, Danielle De Farias, Talita Silveira, Jayr Schmidt Filho, Valeria Buccheri, Roberto Silva, Leila Perobelli, Glaciano Ribeiro, Maura Colturato, Nelson Hamerschlak, Pedro Fernandes, Fernanda Santos Azevedo, Carlos Chiattone, Celso Arrais-Rodrigues

Blood (2025) 146 (Supplement 1): 3909.

https://doi.org/10.1182/blood-2025-3909

Published: 2025

Journal Articles

Baseline clinical characteristics of patients with chronic lymphocytic leukemia (CLL) from 11 Latin American countries: A real-world registry analysis

Ana Oliver, Celso Arrais-Rodrigues, Luis Mario Villela Martinez, Macarena Roa, Sofía Rivarola, Lorena Cardozo, Marialejandra Torres Viera, Denisse Castro, Fabiola Valvert, Daniela Trujillo Loaiza, Anelys García Salgado, Victoria Irigoin, Leila Perobelli, Silvana Cigliari, Alana von Glasenapp, Camila Peña, Sally Paredes, Valeria Buccheri, Virginia Lema Spinelli, Augusto Mirolli, Jose Alvarez, Maura Colturato, Ana Ines Landoni, Gislaine Duarte, Marta Zerga, Sabrina ranero Ferrari, Miguel Pavlovsky, Nancy Cristaldo, Laura Fogliatto, Maria Del Rosario Custidiano, Danielle De Farias, Maria Orlova, Fernando Barroso Duarte, Etelvina Macchiavello, Julio Pose Cabarcos, Sérgio Fortier, Julia Laviano, Clarisa Pagano Vilar, Nelson Hamerschlak, Vera Figueiredo, Fernando Pérez-Jacobo, Javier Retamales, Arianna Robles, German Stemmelin, Rosa Rios Jimenez, Henry Quintero, Brady Beltran, Jorge Castillo, Carlos Chiattone, Luis Malpica

Blood (2025) 146 (Supplement 1): 3908.

https://doi.org/10.1182/blood-2025-3908

Published: 2025

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Validation of the artificial intelligence prediction of acute leukemia tool in a Latin American retrospective cohort

More than a bulk: Higher incidence of venous thromboembolism (VTE) in patients with primary mediastinal B-cell lymphoma compared to patients with bulky mediastinal Hodgkin lymphoma

Training program for DATA managers in hematopoietic cell transplantation and advanced cell therapy: A nine-year overview from Brazil

Total marrow irradiation-based, intensified reduced-intensity conditioning regimen for haploidentical hematopoietic cell transplantation with posttransplant cyclophosphamide: A prospective study

Balancing efficacy and safety: IL-15 BCMA CAR-T cells vs. 2nd generation CAR-T in preclinical myeloma model

Impact of high-dose methotrexate in both central nervous system relapse and systemic progression in high-risk DLBCL: A retrospective analysis of a brazilian cohort

Impact of TBI, donor age, and transplant era on outcomes of allogeneic transplantation in acute lymphoblastic leukemia: Evidence from 748 patients in Latin America

Validation of baseline total metabolic tumor volume (TMTV) as a predictor of early progression (POD24) in follicular lymphoma: A retrospective study of 100 patients in Brazil.

Machine learning ensemble models for genetic-based classification of myeloproliferative and myelodysplastic/myeloproliferative neoplasms: Comparing a multinomial vs binomial approach

Manufacturing variability of CAR-T cells in patients with B-cell lymphoma: Findings from the carthiae-1 clinical trial

Dose Escalation shows no benefit compared to continuing ABVD in Hodgkin's lymphoma patients with an interim PET deauville score of 4

Healthcare inequities in Latin America outweigh the benefits of pediatric regimens in adult acute lymphoblastic leukemia

Total marrow irradiation-based, intensified reduced-intensity conditioning regimen for hematopoietic cell transplantation in patients aged 60 years or older: A prospective study

HLA and non-HLA factors in haploidentical donor selection: Insights from a brazilian single-center study

Frontline therapy patterns and outcomes in chronic lymphocytic leukemia: A real-world, multicenter analysis from Latin America.

Implementation of a next generation sequencing painel for lymphoid malignancies in Brazil: First report of molecular features in a low-middle income country

Uncovering the genomic landscape of DLBCL in Latin America: First report of two centers from Brazil and Chile

GMP-compliant generation, expansion, and a preliminary safety evaluation of CMV-specific t cells using a closed system for post-transplant viral control

Concomitant use of venetoclax 100 mg and ketoconazole, a strong CYP3A4 inhibitor, is clinically equivalent to venetoclax 400 mg for treating relapsed or refractory chronic lymphocytic leukemia (CLL): A real-world analysis from the brazilian CLL registry.“

Baseline clinical characteristics of patients with chronic lymphocytic leukemia (CLL) from 11 Latin American countries: A real-world registry analysis

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only